HOLLY BARONE: Open Payments
NPI 1164792875 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,910 in 94 payments from 19 companies in 2025. Trend: 2023 $1,671 · 2024 $2,505 · 2025 $1,910
Food & beverage: $1,810Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $252 |
| GENZYME CORPORATION | 10 | $208 |
| Amgen Inc. | 12 | $195 |
| Janssen Biotech, Inc. | 9 | $180 |
| Organon LLC | 12 | $138 |
| Incyte Corporation | 4 | $104 |
| PFIZER INC. | 5 | $103 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Lilly USA, LLC | 5 | $100 |
| Regeneron Healthcare Solutions, Inc. | 4 | $98 |
Products named: DUPIXENT, OTEZLA, TREMFYA, RINVOQ, VTAMA, OPZELURA, EUCRISA, Zoryve.
Industry payments across MI — which companies pay providers there.
